Diagnostic testing for anyone, anywhere
Nanjing Synthgene Medical Technology Co., Ltd. is a biomedical high-tech enterprise focusing on the development and production of OTC home self-inspection products. The company has a mature technology platform, including chromatography platform, isothermal amplification platform, etc. The product line covers infectious disease detection, pregnancy diagnosis, drug detection, pet disease diagnosis, gastrointestinal function detection and other fields. At the same time, the company is also developing smart detection products suitable for home self-testing.
Promote accurate diagnosis of human diseases with high-quality diagnostic products, and contribute to the cause of human health.
R & D personnel
Master degree or above
GND raw material
Nearly 7,500 new monkeypox cases were reported globally last week, a 20 percent increase from the previous week, with almost all of the cases in Europe and the Americas, according to the World Health Organization.
Shenji Bio is committed to technology research and product development around core raw materials such as nucleosides, nucleotides, and diagnostic antigens and antibodies. In the future, the company will be more determined to set sail along the road of technological innovation, and pursue its own perfection with unremitting efforts!
On May 24, Nanjing Synthgene Medical Technology Co., Ltd.. (hereinafter referred to as "Synthgene") developed products "Monkeypox Virus Nucleic Acid Detection Kit (RT-PCR Method)", Monkeypox Virus Antigen Detection Kit (Colloidal Gold Method) ), monkeypox virus antibody detection kit (colloidal gold method) three products have obtained EU CE certificate at the same time, the approval of this series of products means that these kits can be sold in EU countries and countries that recognize EU CE certification, and can further It broadens the application fields of the company's products and responds more comprehensively to the needs of overseas markets.
At present, the SARS-CoV-2-related testing products independently developed and produced by Synthgene have been sold in more than 30 overseas countries, and were approved by the State Food and Drug Administration on April 1, 2022 (Registration Certificate No.: National Machinery Note 20223400427), officially launched!